Evidence map›Paper›PMID 39403051›Full record

ReviewCardiovascular & hematological agents in medicinal chemistry2024

Insights into Kinases of ESKAPE Pathogens for Therapeutic Interventions.

Deepansh Mody, Priyanka Joshi, Monika Antil, Rakesh K Gupta, Vibha Gupta

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cardiovascular & hematological agents in medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deepansh ModyDepartment of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Canada.
Priyanka JoshiDepartment of Biotechnology, Jaypee Institute of Information Technology, Sector-62, Noida, U.P., 201307, India.
Monika AntilDepartment of Biotechnology, Jaypee Institute of Information Technology, Sector-62, Noida, U.P., 201307, India.
Rakesh K GuptaDepartment of Microbiology, RLA College, University of Delhi, New Delhi, 110021, India.
Vibha GuptaDepartment of Biotechnology, Jaypee Institute of Information Technology, Sector-62, Noida, U.P., 201307, India.

Funding

Indian Council of Medical Research ISRM/Adhoc/41/2020-21
6 · The paper itself

Abstract

Multidrug-resistant ESKAPE pathogens are the leading cause of hospital-acquired infections across the globe, posing challenges for clinicians. Random genetic mutations and constant exposure to antibiotics in healthcare settings result in strains resistant to commonly used antibiotics, creating life-threatening conditions. If the magic of "antibiotics" is to be sustained, a new class of antimicrobials against novel targets is urgently needed. This necessitates understanding and identifying novel biochemical pathways and bacterial virulence factors that can be targeted for therapeutic interventions. Keeping in view the unambiguous role of the kinome in bacterial survival and virulence, this review provides a survey of effector bacterial kinases involved in evading host immune responses and drug resistance. The formation of biofilms is a critical feature associated with the pathogenesis and survival of ESKAPE organisms in the hostile host milieu. Hence, kinases involved in the biofilm pathway are also elucidated for clinical relevance. In addition, endeavors in the development of therapeutics against ESKAPE kinases are also summarized to provide direction to researchers pursuing the field.

Indexed as

Anti-Bacterial AgentsBiofilmsAnimalsBacteriaBacterial InfectionsCross InfectionDrug Resistance, Multiple, BacterialHumansPhosphotransferasesProtein KinasesAnti-Bacterial AgentsPhosphotransferasesProtein Kinasesantimicrobial resistanceESKAPEkinase inhibitorsKinasestherapeuticstwo-component systems.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.